Why doctors have a moral imperative to prescribe and support medical cannabis—an essay by David Nutt

D Nutt - bmj, 2022 - bmj.com
Why doctors have a moral imperative to prescribe and support medical cannabis—an essay
by David Nutt | The BMJ Skip to main content Intended for healthcare professionals Access …

Why medical cannabis is still out of patients' reach—an essay by David Nutt

D Nutt - BMJ, 2019 - bmj.com
Why medical cannabis is still out of patients’ reach—an essay by David Nutt | The BMJ Skip to
main content Intended for healthcare professionals Access provided by Google Indexer …

Medical cannabis in the UK

A Stevens - Bmj, 2018 - bmj.com
Do patients have the right to medicate themselves, or should they be punished for doing so?
Should their doctors work with them to decide on the best treatment, or does the government …

The case for medical cannabis—An essay by MP Barnes

MP Barnes - Bmj, 2018 - bmj.com
Legal restrictions on the grounds that cannabis has no therapeutic use have impeded
research, says MP Barnes, but evidence shows cannabinoids may have benefit in several …

So near yet so far: why won't the UK prescribe medical cannabis?

D Nutt, S Bazire, LD Phillips, AK Schlag - BMJ open, 2020 - bmjopen.bmj.com
Although cannabis-based products for medicinal use are now legal in the UK, it is still
challenging for patients to gain access, and only very few National Health Service …

Cannabis, cannabis everywhere: UK to review medical cannabis policy as Canada plans imminent legalisation for all uses

R Hurley - BMJ: British Medical Journal (Online), 2018 - search.proquest.com
Cannabis, cannabis everywhere: UK to review medical cannabis policy as Canada plans
imminent legalisation for all uses Page 1 WAR ON DRUGS Cannabis, cannabis everywhere …

Medical cannabis:“restrictive” guidance lets patients down, say campaigners

R Hurley - BMJ: British Medical Journal (Online), 2018 - search.proquest.com
The move to change medicinal products derived from cannabis to schedule 2 of the 2001
Misuse of Drugs Regulations came after advice from England's chief medical officer, Sally …

Benefits and risks of cannabinoids

TP Freeman, W Hall - bmj, 2023 - bmj.com
Cannabis is used by an estimated 219 million adults globally (4.3% of the population) with a
particularly high prevalence in North America (17.4% of the population). 1 The 1961 UN …

Cannabis as medicine

G Newton-Howes - BMJ, 2017 - bmj.com
From its first recorded uses in China through to the early 20th century, cannabis has had a
place in the pharmacopoeia. Queen Victoria's personal physician, Russel Reynolds, opined …

Medicinal use of cannabis based products and cannabinoids

TP Freeman, C Hindocha, SF Green, MAP Bloomfield - Bmj, 2019 - bmj.com
Until recently, cannabis and its derivatives were widely restricted under legislation which
stated they had no medical value and carried a substantial risk of misuse. Policy is rapidly …